{
    "title": "Lonza's first-half core EBITDA gains 16.5%",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11038345/Lonzas-half-core-EBITDA-gains-16-5.html",
    "date": "2022-07-22",
    "keywords": [
        "burger",
        "drug",
        "lonza",
        "core",
        "ebitda",
        "growth",
        "company",
        "investment",
        "july",
        "contract",
        "manufacturer",
        "demand",
        "interest",
        "tax",
        "depreciation",
        "amortisation",
        "statement",
        "friday",
        "analyst",
        "consensus",
        "year",
        "currency",
        "improvement",
        "margin",
        "goal",
        "push",
        "cell",
        "gene",
        "plan",
        "month",
        "franc",
        "switzerland",
        "supplier",
        "vaccine",
        "maker",
        "moderna",
        "sector",
        "reporting",
        "miranda",
        "murray"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}